# MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population

> **NCT05364541** · NA · UNKNOWN · sponsor: **Heart Test Laboratories, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Health Screening

## Interventions

- **DEVICE:** MyoVista wavECG

## Key facts

- **NCT ID:** NCT05364541
- **Lead sponsor:** Heart Test Laboratories, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-11-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364541, "MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05364541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*